Alcon (NYSE:ALC) shares fell 9% in premarket trading on Wednesday, after the Swiss-American pharmaceutical and medical device ...

A nationwide recall of over 75,000 cases of eye care products, including artificial tears and ophthalmic gels, was announced ...

Press Release Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial Several aqueous humor parameters ...

Rookie Wire looked at the upcoming draft class following the lottery and where things stand before the early entry withdrawal ...

US President, Donald Trump, on Wednesday, told interim Syrian President Ahmed al-Sharaa that his order to lift sanctions on Syria is a major policy shift, describing it as an “honour”.White House ...

Before Trump announced his intentions to lift US sanctions on Syria yesterday, it had been designated a state sponsor of ...

One of the world's leading causes of irreversible vision loss could begin with elevated eye pressure, according to a recent ...

Glaucoma damages the optic nerve, leading to irreversible vision loss. It is a leading cause of blindness worldwide. Glaucoma ...

Several types of eye drops sold nationwide have been recalled due a manufacturing issue which can cause a health hazard ...

More than 70,000 cases of ophthalmic products are being recalled for manufacturing deviations, according to a press release by distributor AvKARE. The recalled products, which include eye drops and ...

The pharmaceutical testing lab BRS Analytical Service recalled products used to relieve dry and irritated eyes after ...

Explore Alcon Inc.'s Q1 2025 highlights: new product launches like Unity VCS & PanOptix Pro driving growth, resilient strategies, and updated sales guidance.